GURUFOCUS.COM » STOCK LIST » Financial Services » Credit Services » Xtacy Therapeutics Corp (XCNQ:XTCY) » Definitions » 3-Year Revenue Growth Rate

Xtacy Therapeutics (XCNQ:XTCY) 3-Year Revenue Growth Rate : -47.70% (As of Jun. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Xtacy Therapeutics 3-Year Revenue Growth Rate?

Xtacy Therapeutics's Revenue per Share for the three months ended in Jun. 2024 was C$0.00.

During the past 3 years, the average Revenue per Share Growth Rate was -47.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Xtacy Therapeutics was -47.70% per year. The lowest was -47.70% per year. And the median was -47.70% per year.


Competitive Comparison of Xtacy Therapeutics's 3-Year Revenue Growth Rate

For the Credit Services subindustry, Xtacy Therapeutics's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtacy Therapeutics's 3-Year Revenue Growth Rate Distribution in the Credit Services Industry

For the Credit Services industry and Financial Services sector, Xtacy Therapeutics's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Xtacy Therapeutics's 3-Year Revenue Growth Rate falls into.



Xtacy Therapeutics 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Xtacy Therapeutics  (XCNQ:XTCY) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Xtacy Therapeutics 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Xtacy Therapeutics's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Xtacy Therapeutics Business Description

Traded in Other Exchanges
Address
1100 - 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6
Xtacy Therapeutics Corp Formerly Global Wellness Strategies Inc is a debt financing company. The company provides a debt financing facility to help companies build their valuation and get to the next level in its financing cycle without giving away equity prematurely in their growth cycle. It is focusing on providing finance to medical cannabis, hemp, and CBD-related, healthcare-related target companies.

Xtacy Therapeutics Headlines

No Headlines